Annual Conference
Save the Date
NCCN 2026 Annual Conference
Friday, March 27 – Sunday, March 29, 2026
Caribe Royale Orlando, Orlando, FL
Continuing Education
Conference attendees will have the opportunity to view conference sessions on-demand in the Virtual Event Platform through June 2025. Recorded presentations will be available on the NCCN Continuing Educational Portal, education.nccn.org, in late June 2025.
- CE/MOC credit was available for the oncology team, including oncologists in the academic and community settings, nurse practitioners, nurses, PAs, pharmacists, case managers, and other health care professionals.
- More than 30 live and on-demand educational sessions were offered.
- Challenging cases and panel discussions took place.
- Concurrent sessions covered best practices in oncology, including AI tools, safe telehealth delivery, reducing stigmas, expanding access, and more!
2025 Plenary Sessions:
- Addressing Mental Health for Patients & Survivors
- Implementing AI in Oncology
Clinical Updates in Oncology:
Explore NCCN Guidelines® updates.
- Gastrointestinal Cancers
- Genitourinary Cancers
- Gynecologic Cancers
- Hematologic Malignancies
- Hereditary Cancers
- Smoking Cessation
Best Practices in Oncology:
Delve into issues affecting care delivery.
- Building Patient Navigation Models
- Ensuring Safe Telehealth Delivery
- Expanding Clinical Trials & Recruitment
- Improving Patient Access & Outcomes
Supported by educational grants from:
- AstraZeneca
- BeiGene
- Coherus BioSciences
- Eisai, Inc.
- Exact Sciences
- Ferring Pharmaceuticals
- Genentech, a member of the Roche Group
- Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
- Lantheus
- Lilly
- Menarini-Stemline
- Novartis
- Novocure
- Pharmacosmos Therapeutics Inc.
- Puma Biotechnology
- Taiho Oncology, Inc.
Supported by independent medical education grants from:
- AbbVie
- ADC Therapeutics
- Boehringer Ingelheim Pharmaceuticals, Inc.
- GSK
- Jazz Pharmaceuticals
- Rigel Pharmaceuticals, Inc.
Supported by independent educational grants from:
- Daiichi Sankyo
- Incyte Corporation
- Merck & Co., Inc., Rahway, NJ, USA
This activity is supported by funding from Blue Earth Diagnostics, A Bracco Company.
This educational activity is supported by a medical education grant from Exelixis, Inc.
This project has been made possible in part by a grant from Varian Medical Systems, a Siemens Healthineers company /Global Medical Education Grant Program.
Exhibit Hall
Conference attendees can view virtual exhibits in the Virtual Event Platform through June 2025.
For exhibitor opportunities, contact [email protected].
2025 Conference Sponsors
Platinum Level
Gold Level
Eisai Inc.
Johnson & Johnson
Regeneron
Bronze Level
AstraZeneca
BeOne Medicines
Geron Corporation
GSK
Jazz Pharmaceuticals
LeanTaaS
Servier Pharmaceuticals
Patient Advocacy Pavilion Sponsors
Emerald
AstraZeneca
BeOne Medicines
Coherus Biosciences
Eisai Inc.
Incyte Corporation
Johnson & Johnson
Servier Pharmaceuticals
Topaz
Important Alert About Fraudulent Sites
Information about this Conference may appear on fraudulent websites that appear to offer registration, exhibit space, and hotel rooms at discounted rates. These companies are in no way affiliated with NCCN. Please do not book any registrations or reservations through these sites, and register only through NCCN. If you have any questions or concerns, contact [email protected].